CPNG

Coupang, Inc.

$14.34

+0.49% 2026-10-19

Consumer Cyclical

1M 3M 6M 1Y 2Y

CPNGSPY

-6.2%

+0.3%

-12.8%

-33.3%

YTD

-39.2%

-54.1%

Grades vs sector

Momentum

no data

–

Percentile within its GICS sector across the S&P 1500.

Growth

no data

–

Percentile within its GICS sector across the S&P 1500.

Value

no data

–

Percentile within its GICS sector across the S&P 1500.

Profitability

no data

–

Percentile within its GICS sector across the S&P 1500.

Revisions

no data

–

30-day change in analysts' current-year EPS estimate; graded across covered stocks.

Our models

Not held by any of our 3 live models right now.

Momentum Top 15

not ranked (outside this model's universe or screens)

Quality Growth

not ranked (outside this model's universe or screens)

Momentum Blend

not in the current book

Key stats

Market cap$25.8B

P/E (trailing)–

P/E (forward)51.7

52-week range13.35 – 32.35

Revenue growth (YoY, latest qtr)+3.9%

Dividend yield0.00%

Analyst consensusBuy (18)

Mean price target$23.39 (+63%)

Valuation & fundamentals

Bottom line

Leans expensive

Model read-out from the numbers below, not advice. Score -1 (DCF counts double).

▼DCF (base case)below the price by 78%

•Piotroski F-score6/9

•Altman Z2.5 (grey)

▲Analyst target+63% (18 analysts)

Discounted cash flow

Bear

-81%

growth 6% · disc. 11.1% · term. 2.0%

Base

-78%

growth 11% · disc. 10.1% · term. 2.5%

Bull

-74%

growth 14% · disc. 9.1% · term. 3.0%

A DCF starts from trailing free cash flow, so it can overstate value if the last 12 months were unusually strong (or weak). Use the bear case or edit the starting cash flow if so.

Reverse DCFfor context, not a signal

Today's price assumes free cash flow grows about 42% a year for 10 years.

Implied

+42%/yr

FCF, last 3 yrs

n/a

FCF, last 5 yrs

n/a

Revenue, last 3 yrs

+19%/yr

Revenue, last 5 yrs

+24%/yr

Same inputs as the DCF above: trailing free cash flow 0.1B, 10.1% discount rate, 2.5% growth after year 10, net cash and today's share count. Actual growth rates are compound annual rates from SEC annual filings through FY2025; "n/a" means too little history or a negative starting year.

Edit assumptions · recalculates instantly

Your value per share–

Free cash flow = operating cash flow − capital spending, trailing 12 months (TTM to 2026-06-30). Growth default: average of 3-year revenue CAGR and latest revenue growth, capped at 30%. Years 6–10 fade linearly to terminal growth. Discount rate = 4.25% risk-free assumption + beta 1.17 × 5% equity premium, kept within 7–13%. Bear: lower growth, +1 pt discount, 2% terminal. Bull: higher growth, −1 pt, 3%.

Multiples vs sector

Forward EPS $0.28 vs trailing $-0.43. Forward P/E uses analysts' next-12-month estimate.

Quality & financial health

Gross margin

28.4%

Operating margin

-1.8%

FCF margin

0.3%

Net margin

-2.2%

Return on equity

-18.8%

Return on invested capital

-85.2%

Net debt / EBITDA

–

Current ratio

0.9×

Interest cover

-8.3×

Cash conversion (OCF/NI)

–

Piotroski F-score 6/9 · last two fiscal years

✓ Positive net income✓ Positive operating cash flow✓ Return on assets improved✓ Cash flow above net income✓ Long-term debt / assets fell✗ Current ratio improved✗ No share dilution✓ Gross margin improved✗ Asset turnover improved

Altman Z-score 2.5 (grey zone; above 3.0 = safe, below 1.8 = distress). Not meaningful for banks and insurers.

Analysts

Mean target

$23

+63%

Analysts

Buy

Range

$12–$30

low – high

● price · ◆ mean target

Annual history

FY	Revenue	Net income	Free cash flow
2025	$34.5B	$208.0M	$522.0M
2024	$30.3B	$154.0M	$1.0B
2023	$24.4B	$1.4B	$1.8B
2022	$20.6B	$-92.0M	$-259.0M
2021	$18.4B	$-1.5B	$-1.1B
2020	$12.0B	$-463.2M	$-183.1M

From the company's 10-K filings via SEC XBRL. 3-year revenue CAGR +18.8%.

Earnings

Next report: 2026-11-03 · during market · EPS est -0.01

EstimateActual (beat)Actual (miss)

Report	EPS est	Actual	Surprise
2026-08-04	-0.29	-0.09	+69.1%
2026-05-05	-0.09	-0.15	-70.5%
2026-02-26	0.05	-0.01	-122.2%
2025-11-04	0.04	0.05	+25.0%
2025-08-05	0.05	0.02	-58.6%
2025-05-06	0.05	0.05	+9.0%
2025-02-25	0.01	0.04	+370.0%
2024-11-05	0.01	0.06	+534.2%

Quarterly revenue

Quarter	Revenue	YoY
2026-06-30	$8.9B	+3.9%
2026-03-31	$8.5B	–
2025-12-31	$8.8B	–
2025-09-30	$9.3B	–
2025-06-30	$8.5B	–

Analyst actions

B of A Securities

2026-08-06 · main

Buy → Buy
PT $24

Deutsche Bank

2026-08-06 · up

Hold → Buy
PT $22

Mizuho

2026-07-29 · main

Neutral → Neutral
PT $24

Barclays

2026-07-07 · main

Overweight → Overweight
PT $29

B of A Securities

2026-06-25 · main

Buy → Buy
PT $27

CLSA

2026-06-15 · init

→ Outperform
PT $24

Insider trades

Lee Jonathan D.

Chief Accounting Officer · 2026-10-02

SELL
$75.3K

Rogers Harold

See Remarks · 2026-08-10

SELL
$3.1M

Lee Jonathan D.

Chief Accounting Officer · 2026-08-10

SELL
$88.9K

News

1 Mid-Cap Stock on Our Buy List and 2 We Turn Down

StockStory · 17h ago

Why Coupang, Inc. (CPNG) Dipped More Than Broader Market Today

Zacks · Oct 16

Alibaba vs. Coupang: Which E-Commerce Giant Is a Better Buy in 2026?

Motley Fool · Oct 15

Coupang vs. Uber Technologies: Decelerating Versus Steady Revenue Growth

Motley Fool · Oct 15

Coupang vs. Uber Technologies: Which Consumer Stock Is a Better Buy in 2026?

Motley Fool · Oct 14

Coupang vs. Shopify: Absolute Scale vs. Seasonal Spikes in Revenue

Motley Fool · Oct 13

2 Stocks That Could Double by 2031

Motley Fool · Oct 13

Can Coupang (CPNG) Turn Customer Retention Into Margin Expansion?

Insider Monkey · Oct 13

Coupang, Inc. (CPNG) Falls More Steeply Than Broader Market: What Investors Need to Know

Zacks · Oct 12

Stats refreshed 2026-10-19 19:02:25 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now

coteau

Coteau Systematic StrategiesSystematic equity research and model portfolios.
Coteau Systematic Strategies publishes research, model portfolios and tools. It does not manage money or offer investment advice. Model results are hypothetical. Data: Yahoo Finance (delayed), SEC EDGAR.

What is Coteau?Disclaimer Terms Privacy Data status